Full-Thickness Tumor Resection of Oral Cancer Involving the Facial Skin—Microsurgical Reconstruction of Extensive Defects after Radical Treatment of Advanced Squamous Cell Carcinoma by Moratin, Julius et al.
cancers
Article
Full-Thickness Tumor Resection of Oral Cancer Involving the
Facial Skin—Microsurgical Reconstruction of Extensive Defects
after Radical Treatment of Advanced Squamous Cell Carcinoma
Julius Moratin 1,* , Jan Mrosek 1 , Dominik Horn 2, Karl Metzger 1 , Oliver Ristow 1, Sven Zittel 1,
Michael Engel 1, Kolja Freier 2, Juergen Hoffmann 1 and Christian Freudlsperger 1


Citation: Moratin, J.; Mrosek, J.;
Horn, D.; Metzger, K.; Ristow, O.;
Zittel, S.; Engel, M.; Freier, K.;
Hoffmann, J.; Freudlsperger, C.
Full-Thickness Tumor Resection of
Oral Cancer Involving the Facial
Skin—Microsurgical Reconstruction
of Extensive Defects after Radical
Treatment of Advanced Squamous
Cell Carcinoma. Cancers 2021, 13,
2122. https://doi.org/10.3390/
cancers13092122
Academic Editor: Christian Simon
Received: 15 March 2021
Accepted: 27 April 2021
Published: 28 April 2021
Publisher’s Note: MDPI stays neutral
with regard to jurisdictional claims in
published maps and institutional affil-
iations.
Copyright: © 2021 by the authors.
Licensee MDPI, Basel, Switzerland.
This article is an open access article
distributed under the terms and
conditions of the Creative Commons
Attribution (CC BY) license (https://
creativecommons.org/licenses/by/
4.0/).
1 Department of Oral and Cranio-Maxillofacial Surgery, University of Heidelberg, Im Neuenheimer Feld 400,
D-69120 Heidelberg, Germany; jan.mrosek@med.uni-heidelberg.de (J.M.);
karl.metzger@med.uni-heidelberg.de (K.M.); oliver.ristow@med.uni-heidelberg.de (O.R.);
sven.zittel@med.uni-heidelberg.de (S.Z.); michael.engel@med.uni-heidelberg.de (M.E.);
juergen.hoffmann@med.uni-heidelberg.de (J.H.); christian.freudlsperger@med.uni-heidelberg.de (C.F.)
2 Department of Oral and Cranio-Maxillofacial Surgery, Saarland University Hospital, Kirrberger Straße,
D-66424 Homburg, Germany; dominik.horn@uks.eu (D.H.); kolja.freier@uks.eu (K.F.)
* Correspondence: julius.moratin@med.uni-heidelberg.de; Tel.: +49-6211-39795
Simple Summary: Advanced malignant tumors of the oral cavity are challenging because they
impose serious oncological and functional requirements on the treatment specialist. Depending on
the localization and the extent of the primary tumor, a full-thickness resection affecting the facial
skin may be necessary to achieve a complete tumor resection. The resulting defects need adequate
reconstruction in order to restore the aesthetics and functionality of the orofacial system. In this
retrospective analysis, the authors aimed to evaluate treatment techniques for these tumors and
analyze the clinical outcome of the related procedures. Full-thickness tumor resection with free flap
reconstruction due to advanced cancer was performed in 33 patients.
Abstract: Advanced tumors of the head and neck are challenging for the treatment specialist due to
the need to synergize oncological and functional requirements. Free flap reconstruction has been
established as the standard of care for defects following tumor resection. However, depending on the
affected anatomic subsite, advanced tumors may impose specific difficulties regarding reconstruction,
especially when full-thickness resection is required. This study aimed to evaluate reconstructive
strategies and oncological outcomes in patients with full-thickness resection of the oral cavity. A
total of 33 patients with extensive defects due to squamous cell carcinoma of the oral cavity were
identified. Indications, reconstructive procedures, and clinical outcome were evaluated. Thirty-two
patients (97%) presented locally advanced tumors (T3/T4). Complete tumor resection was achieved
in 26 patients (78.8%). The anterolateral thigh flap was the most frequently used flap (47.1%), and the
primary flap success rate was 84.8%. The cohort demonstrated a good local control rate and moderate
overall and progression-free survival rates. Most patients regained full competence regarding oral
alimentation and speech. Full-thickness tumor resections of the head and neck area may be necessary
due to advanced tumors in critical anatomic areas. In many cases, radical surgical treatment leads
to good oncological results. Free flap reconstruction has been shown to be a suitable option for
extensive defects in aesthetically challenging regions.
Keywords: oral cancer; free flaps; HNSCC
1. Introduction
Head and neck squamous cell carcinomas (HNSCCs) are among the seven most
common malignant tumors global and a significant portion of these tumors arises from
the mucosa of the oral cavity [1]. Despite recent advances in the therapy of HNSCC by the
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introduction of immune checkpoint inhibition for recurrent/metastatic tumors, surgery
and/or primary (chemo-)radiotherapy remain the only primary therapeutic options for
most patients [2–4]. Advanced tumors, in particular, impose a challenge to both the patients
suffering from the disease and the treating specialist, due to a trade-off between oncological
necessities, and functional and aesthetic requirements, that is inevitable in many cases of
head and neck tumor therapy. Although primary chemo-radiation is a relevant option for
head and neck cancer patients, factors including tumor localization, prior adjuvant therapy
in cases of recurrent tumors, other medical reasons, or the individual decisions of patients
and treating specialists, leave surgery as the only curative therapy for advanced tumors in
many cases.
The need for a complete resection of oral tumors with safe surgical margins may lead
to extensive defects including full-thickness perforations involving the facial or the cervical
skin. While small defects after surgical tumor ablation may be restored using local wound
closure, split skin grafts, or regional flaps, extensive defects in most cases require the use of
free flaps to achieve an adequate result in terms of function and aesthetics [5–9].
Although reconstructive surgery of the head and neck region is a well-established
field in many centers, the preparedness and the expertise for extensive resections resulting
in full-thickness defects and consequent reconstructions may vary. This may lead to
undertreatment of patients, affecting both oncologic and functional outcomes in terms
of post-therapeutic quality of life. The purpose of the presented study, therefore, was
to present an overview of reconstructive strategies and clinical outcomes in a cohort of
patients with full-thickness tumor resections of squamous cell carcinomas of the oral cavity.
2. Results
2.1. Patients
A total of 33 patients were included in the analysis; 12 (36.4%) were female and 21
(63.6%) were male, with a mean age of 67 ± 13.7 years and a range from 25 to 95 years.
All patients received surgical therapy in the Department of Oral and Cranio-Maxillofacial
Surgery of the Heidelberg University Hospital. Twenty-two (66.7%) patients suffered from
primary oral squamous cell carcinoma and 11 (33.3%) were treated because of a local or
locoregional tumor recurrence. Table 1 provides detailed information on demographic,
clinical, and pathological features of the investigated cohort.
Table 1. Descriptive data regarding demographic and clinical features of the investigated cohort.










Primary or Recurrent Tumor
Primary tumor 21 (63.6)
Recurrent tumor (local recurrence) 12 (36.4)
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Table 1. Cont.
Parameter Number of Cases (%)
Tumor Localization
Mandible + Floor of the mouth 20 (60.6)























Lymphatic invasion 15 (45.5)
Vascular invasion 4 (12.1)
Perineural invasion 12 (36.4)
2.2. Therapeutic Procedures
All patients underwent surgical therapy due to primary or recurrent squamous cell
carcinoma of the oral cavity. Complete tumor resection (R0) was achieved in 26 patients
(78.8%), incomplete tumor resection (R1) was performed in six patients (18.2%). In one
patient (3.0%) resection status was unclear (Rx) due to a fragmented preparation. Most
cases of incomplete tumor resections (5/6, 83.3%) were related to tumors of the floor of the
mouth/mandible.
The whole cohort of 33 patients had an indication for postoperative adjuvant therapy
due to advanced tumor stage, the presence of neck node metastases, incomplete tumor
resection status, histopathological risk factors (L+, V+, pN+), or a combination of several
factors. In fact, only 15 patients (45.5%) received postoperative (chemo-)radiation. The
remaining patients did not receive adjuvant treatment due to a history of prior radiotherapy
(n = 11/33.3%), reduced medical condition or incomplete wound healing after surgery
(n = 3/9.1%), and patients’ refusal (n = 4/12.1%).
2.3. Surgical Technique
All patients received full-thickness tumor resection due to an involvement of the
external facial/cervical skin by the tumor mass and the intention to obtain tumor-free
resection margins. The most commonly affected area was the cheek (n = 23/69.7%),
followed by the submental/submandibular region (n = 10/30.3%), whereas the most
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commonly affected primary tumor sites were the mandible, including the floor of the
mouth (n = 20/60.6%) and the buccal mucosa (n = 8/24.2%) (Table 1).
Free flap reconstruction was performed in all patients. Primary reconstruction was
successful in 28 patients (84.8%) and flap loss occurred in five patients (15.2%). In all
patients with a failure of the first flap, a second free flap reconstruction was performed
successfully using an ALT flap (n = 5). The types of free flaps used for defect restoration
included the anterolateral thigh flap (ALT, n = 24/82.7%), the radial forearm flap (RFF,
n = 3/9.1%), the scapula flap (n = 3/9.1%), the fibula flap (n = 2/6.1%), and the latissimus
dorsi flap (n = 1/3%). Soft-tissue flaps were prepared for the restoration of full-thickness
defects by partial de-epithelization to create two separated skin paddles (Figure 1).




Figure 1. Schematic diagram of a partially de-epithelialized ALT flap and an osteosynthesis plate 
for the reconstruction of a full-thickness defect after tumor resection with segmental resection of 
the left-sided mandible. After segmental resection and the individualization of an osteosynthesis 
plate, the ALT flap was harvested. The prepared flap then underwent partial de-epithelialization 
in order to create two skin paddles for restoration of the oral and the facial defect. 
2.4. Perioperative Management 
The mean hospitalization period for all patients was 23.1 ± 10.9 days with a range 
from 9 to 53 days. Two patients (6.1%) died during their hospitalization period due to 
postoperative complications. A total of 24 patients (72.7%) were temporarily dependent 
on a tracheostomy for a mean duration of 23.4 ± 32.4 days. Twelve patients (36.4%) were 
temporarily or constantly dependent on a percutaneous endoscopic gastrostomy (PEG). 
2.5. Outcome 
2.5.1. Oncological Outcome 
The mean follow-up period was 21 ± 23 months with a range from 1 to 91 months. 
Overall survival, progression-free survival and the local control rate for the investigated 
cohort are depicted in Figure 2. Twelve patients (36.4%) experienced disease progression 
and 12 patients (36.4%) died during follow-up. The patients with disease progression de-
veloped a local recurrence in six cases (50%), regional recurrence in two cases (16.7%), and 
distant metastases in four cases (33.3%), all of which were located in the lung. 
Figure 1. Sche atic diagram of a partially de-epithelialized ALT flap and an osteosynthesis plate
for the reconstruction of a full-thickness defect after tumor resection with segmental resection of the
left-sided mandible. After segmental resection and the individualization of an osteosynthesis plate,
the ALT flap was harvested. The prepared flap then underwent partial de-epithelialization in order
to create two skin paddles for restoration of the oral and the facial defect.
Tables 2 and 3 provide an overview of types of free flaps used for reconstruction
after full-thickness resection and corresponding success-rates and Table 4 provides a set of
considerations regarding the ALT flap as technique of choice for full-thickness defects of
the head and neck area.
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Table 2. Overview of reconstructive strategies and success rates in relation to affected anatomical
subsite of the oral cavity.
Affected Subsite of the Oral Cavity Free Flap (no.) Success Rate
Mandible + Floor of the Mouth
ALT (n = 15) 12/15 (80%)
RFF (n = 1) 1/1 (100%)
Scapula (n = 1) 1/1 (100%)
Fibula (n = 2) 2/2 (100%)
Buccal Mucosa
ALT (n = 7) 7/7 (100%)
RFF (n = 1) 1/1 (100%)
Maxilla
ALT (n = 2) 2/2 (100%)
RFF (n = 1) 1/1 (100%)
Scapula (n = 2) 0/2 (0%)
Table 3. Overview on free flaps used for the restoration of full-thickness defects with revision and
success rates.
Type of Free Flap Revision Rate Success Rate
ALT 4/24 (16.7%) 21/24 (87.5%)
RFF 0/3 3/3 (100%)
Scapula 3/3 (100%) 1/3 (33.3%)
Fibula 0/2 2/2 (100%)
Latissimus dorsi 0/1 1/1 (100%)
Table 4. Considerations regarding the ALT flap as reconstructive technique of choice for full-thickness
defects of the head and neck area.
Advantages of ALT Flaps
• Good pedicle length
• Especially suitable for extensive defects due to its bulkiness
• Partial de-epithelization allows for the restoration of several neighboring defects, even if
only one perforator is found
• Low donor-site morbidity and high rate of primary closure of donor-sites
• Low surgery times due to the possibility of a two-team approach
Disadvantages of ALT Flaps
• Risk of aesthetic and functional impairment if a bulky flap is used for narrow defects
• Risk of compromising the perforator if ALT is used for the coverage of metal plates
• Need for secondary osseous reconstruction in cases of mandibular resections
2.4. Perioperative Management
The mean hospitalization period for all patients was 23.1 ± 10.9 days with a range
from 9 to 53 days. Two patients (6.1%) died during their hospitalization period due to
postoperative complications. A total of 24 patients (72.7%) were temporarily dependent
on a tracheostomy for a mean duration of 23.4 ± 32.4 days. Twelve patients (36.4%) were
temporarily or constantly dependent on a percutaneous endoscopic gastrostomy (PEG).
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2.5. Outcome
2.5.1. Oncological Outcome
The mean follow-up period was 21 ± 23 months with a range from 1 to 91 months.
Overall survival, progression-free survival and the local control rate for the investigated
cohort are depicted in Figure 2. Twelve patients (36.4%) experienced disease progression
and 12 patients (36.4%) died during follow-up. The patients with disease progression
developed a local recurrence in six cases (50%), regional recurrence in two cases (16.7%),
and distant metastases in four cases (33.3%), all of which were located in the lung.
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Figure 2. Kaplan–Meier curves depicting (a) overall survival, (b) progression-free survival, and (c) local control rate of the 
investigated cohort with full-thickness resections following advanced oral squamous cell carcinoma during a follow-up 
period of up to 60 months. Overall and progression-free survival rates exhibit a decrease to about 50% after 20–30 months, 
the local control rate shows a decrease to about 75% after 20 months. 
2.5.2. Functional Outcome 
In all patients, adequate reconstruction was achieved using a free flap. Although 12 
patients (36.4%) were temporarily dependent on a percutaneous gastrostomy, the remain-
ing patients (n = 21/63.6%) were able to maintain sufficient oral nutrition postoperatively. 
Figure 2 exemplifies the preoperative situation, surgical procedures, and postoperative 
outcome of a patient with recurrent squamous cell carcinoma of the maxilla. Figures 3 and 
4 exemplify the preoperative situation, and postoperative outcome of two patients with 
advanced squamous cell carcinoma of the oral cavity. 
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investigated cohort with full-thickness resections following advanced oral squamous cell carcinoma during a follow-up
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the local control rate shows a decrease to about 75% after 20 months.
2.5.2. Functional Outcome
In all patients, adequate reconstruction was achieved using a free flap. Although 12 pa-
tients (36.4%) were temporarily dependent on a percutaneous gastrostomy, the remaining
patients (n = 21/63.6%) were able to maintain sufficient oral nutrition postoperatively.
Figure 2 exemplifies the preoperative situation, surgical procedures, and postoperative out-
come of a patient with recurrent squa ous c ll carcinoma of the maxilla. Figures 3 and 4
exemplify the preoperative situation, and postoperative outcome of two patients with
advanced squamous cell carcinoma of the oral cavity.
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outcome of a patient with recurrent squamous cell carcinoma of the maxilla. Figures 3 and 
4 exemplify the preoperative situation, and postoperative outcome of two patients with 
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Figure 3. Male patient with recurrent squamous cell carcinoma of the left-sided maxilla with infiltration of the maxillary
sinus and facial skin. (a) CT scan depicting the infiltration of the paranasal sinus and the facial skin. (b) Full-frontal image
of the preoperative situation with tumor progression of the left cheek. (c) Full-frontal image of the postoperative situation
after full-thickness tumor resection and reconstruction with ALT flap.
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3. Discussion 
Despite advances in screening and diagnosis of head and neck cancer, a significant 
proportion of patients presents with locally advanced disease [10,11]. As surgical therapy 
remains the primary modality for the treatment of locally advanced oral squamous cell 
carcinomas (OSCCs), the extent of tumor resection has to be carefully balanced against 
possible functional and aesthetic impairments affecting the patient’s quality of life. In pa-
tients in which oral cavity tumors exhibit involvement of the external skin, in particular, 
extensive resection might be challenging and usually requires the use of free flaps for re-
construction. As residual disease is accompanied by worse overall and progression-free 
survival, a critical goal of surgery must be the achievement of clear oncologic margins 
[12]. Nonetheless, radical surgical intervention may lead to functional and aesthetic im-
pairments. 
Hence, the present manuscript exclusively focuses on patients with locally advanced 
OSCCs involving the external skin, independent of their medical history regarding the 
sequence of the disease. This heterogeneous cohort integrating patients with primary and 
recurrent disease was chosen because it offers the possibility to exemplify and discuss 
aspects of synergism between surgical oncology and reconstructive surgery. 
The main objective of oncological surgery is to create tumor-free margins, which in 
this cohort was successfully achieved in 78.8% of the cases. Although this rate generally 
might be critically discussed, it has to be considered under the aspect of the dominance of 
advanced tumors in this cohort (97% T3/T4 tumors), including 36.4% recurrent tumors 
and a history of prior multi-modality-treatment in 33.3% of the patients. Therapeutic con-
siderations for patients with primary disease are generally different from those with re-
current disease, especially regarding potential alternatives. However, the presented co-
hort offers certain peculiarities that should be respected concerning treatment planning. 
Although primary radiotherapy is a valuable option for radiation-naive patients suffering 
from head and neck cancer that offers good local and regional control rates, there are ad-
vantages of a primary surgical approach that should be considered [13]. These include the 
possibility to further improve the outcome if complete tumor resection is achieved, to 
guide adjuvant therapy by possibly detecting occult lymph node metastases, and to re-
store areas where extensive tumor growth may lead to defect healing if primary radio-
Figure 4. Male patient with primary squamous cell carcinoma of the right-sided mandible with infiltration of the facial skin.
(a) Tumor infiltration of the right cheek. (b) CT scan depicting the tumor of the right-sided mandible with infiltration of the
facial skin. (c) Full-frontal image of the postoperative situation after full-thickness tumor resection and reconstruction with
ALT flap.
3. Discussion
Desp te adv nce in screening and di gnosis of head and neck cancer, a significant
proportion of atients presents with locally advanced disease [10,11]. As surgical therapy
remains the primary modality for the treatment of locally advanced oral squamous cell
carcinomas (OSCCs), the extent of tumor resection has to be carefully balanced against pos-
sible functional and aesthetic impairments affecting the patient’s quality of life. In patients
in which oral cavity tumors exhibit involvement of the external skin, in particular, extensive
resection might be challenging and usually requires the use of free flaps for reconstruction.
As residual disease is accompanied by worse overall and progression-free survival, a criti-
cal goal of surgery must be the achievement of clear oncologic margins [12]. Nonetheless,
radical surgical intervention may lead to functional and aesthetic impairments.
Hence, the present manuscript exclusively f cus s on patient with locally advanced
OSCCs involving the external skin, i dependent of the r medical history regarding the
sequence of the disease. This heterog ne us cohort integrating patients with primary and
recurrent disease was chose because it ffers the p ssibility to exemplify and discuss
aspects of synergism between surgical oncology and reconstructive surgery.
The main objective of oncological surgery is to create tumor-free margins, which in
this cohort was successfully achieved in 78.8% of the cases. Although this rate generally
might be critically discussed, it has to be considered under the aspect of the dominance of
advanced tumors in this cohort (97% T3/T4 tumors), including 36.4% recurrent tumors and
a history of prior multi-modality-treatment in 33.3% of the patients. Therapeutic considera-
tions for patients with primary disease are generally different from those with recurrent
disease, especially regarding otential alternatives. However, the presented cohort offers
certain p culiariti s th t should b respected co cerning treatment planning. Although
primary radiotherapy i a valu ble ption for radiation- aive patients suffering from head
and neck cancer that offers good local and regi nal control rates, there are advantages of a
primary surgical approach that should be considered [13]. These include the possibility to
further improve the outcome if complete tumor resection is achieved, to guide adjuvant
therapy by possibly detecting occult lymph node metastases, and to restore areas where
extensive tumor growth may lead to defect healing if primary radiotherapy is applied.
As other therapeutic approaches including the newly introduced immune-checkpoint
inhibition are, at present, restricted to palliative settings and therapeutic response is lim-
ited to a fraction of patients, the affected patients need profound guidance regarding the
implications of the proposed therapies and their rejection [4,14].
Several retrospective and prospective studies evaluated the concept of salvage surgery
for patients suffering from recurrent head and neck cancer, mostly advocating the use of
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free flaps for the reconstruction of large tissue defects [14–18]. Although the term “salvage
surgery” mostly applies to tumor resections with curative intent in patients with recurrent
tumors and a history of previous (radio-) therapies, and consequently lacking alternatives
to the surgical approach, the focus of the present study lies on extensive resections of head
and neck tumors irrespective of the sequence of prior therapy to exemplify the possibilities
and limitations of tumor surgery of the head and neck in general. Consequently, the
presented cohort is heterogeneous regarding the medical history of the patients and limited
in size due to the focus on cases with a need to perform full-thickness tumor resections.
Although most of the mentioned publications focus on salvage surgery approaches, the
general considerations mostly also apply to patients with advanced primary tumors in
sensitive localizations. In every case, critical balancing of the patient’s individual situation
and wishes is urgently warranted, including prognosis, the patient’s physical and mental
capacity, and the chance for therapeutic success.
The oncological results in our analysis demonstrate a high local control rate and,
although the overall and progression-free survival rate is typical for a cohort of patients
suffering from advanced head and neck cancer, only six cases (18.2%) of local recurrence
occurred, and the remaining six cases of disease recurrence were attributable to regional
or distant metastases. These results, although drawn from a small cohort, are comparable
to those reported in the available literature and confirm the validity of our data [19,20].
Furthermore, in many of the presented cases, surgery was the only available curative
therapeutic option due to a history of radiotherapy in the cases of recurrent tumors. In
other cases, a definitive radio(-chemo)-therapy was abandoned because of the tumor’s
vicinity or its manifest infiltration of sensitive structures with a high risk of postoperative
osteonecrosis (e.g., the mandible) [21]. Additionally, extensive tumors carry a risk of a defect
healing after radiotherapy, especially if they cause a connection between the oral cavity
and the facial skin. In those cases, a primary surgical approach to restore the anatomic
integrity of the oral cavity and the facial skin appears sensible for obvious aesthetic and
functional reasons, because there is plethora of publications on the higher complication rate
of reconstructive surgical approaches in patients with a history of radiotherapy [22–24].
The ALT was the most frequently used flap in our cohort. It is a versatile option
for the extensive defects due to its volume, good pedicle length, and comparably low
donor site morbidity [25–28]. It is especially suitable for full-thickness defects, because
partial de-epithelization of the flap allows for the creation of separate skin paddles that
may be tunneled through the defect and may be used for the restoration of the intra- and
extraoral parts of the defect even if only one perforator is present. Other flaps used in our
cohort were the radial forearm flap, the scapula flap, the fibula flap, and the latissimus
dorsi flap. The overall flap success rate in our cohort was 84.8%, which is inferior to that
reported by other authors [18,24]. Flap success rates were different between patients with
primary (flap success: 90.5%) and recurrent disease (75%), which may be explained by the
oft-reported tendency towards higher complication rates in patients with a history of prior
reconstructive approaches and radiotherapy [24,29,30]. Additionally, the general need for
bigger flaps for full-thickness defects may carry an increased risk of flap failure.
Several authors have reported on techniques for the restoration of facial full-thickness
defects. They proposed free flaps including the ALT, the fibula flap, and the radial
forearm flap, alone or in combination with rotational flaps for the extraoral parts of
the defect [31–34]. As most of the reported studies focused on small numbers of pa-
tients, to the best of our knowledge this article describes one of the largest cohorts with
full-thickness defects.
Although there was an accumulation of tumors in distinct subsites of the oral cavity
(mandible/floor of the mouth, buccal mucosa, maxilla) eventually leading to full-thickness
tumor resection, each patient needs individual treatment planning and, thus, patients with
similar expected defects may require different reconstructive approaches to achieve an
optimal or at least satisfying outcome. Several factors are of critical relevance for the choice
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of the reconstructive technique, including medical history, the sequence of reconstruction,
and the patient’s individual physical condition.
This study has several limitations. The retrospective nature of the analysis is prob-
lematic regarding the case selection and the significance of deduced statements. As stated
previously, the focus on a special subset of tumor patients that was mainly defined by
the necessity for full-thickness resection led to a small cohort. The inclusion of primary
and recurrent tumors aggravates the interpretation of the survival data and does not al-
low for valid conclusions. Nevertheless, the authors think that the presented study may
be regarded as a legitimate suggestion for a possible treatment regime for a subset of
head and neck cancer patients that is relevant and challenging regarding oncological and
reconstructive considerations.
4. Materials and Methods
The presented retrospective study was conducted with respect to the principles of the
Declaration of Helsinki and was approved by the local ethics committee of the University
of Heidelberg (Ethic vote: S-183/2015). Written informed consent was given by all patients.
All patients receiving full-thickness tumor resection of a squamous cell carcinoma of the oral
cavity (primary and recurrent tumors) in the Department of Oral and Cranio-Maxillofacial
Surgery of the Heidelberg University Hospital between 2010 and 2020 were included in the
analysis. Secondly, patients who received full-thickness tumor resections were identified
for further investigation. Demographic, clinical, and pathological data were extracted from
the electronic patient records and transferred to an anonymized data processing sheet.
Statistical analysis was performed using IBM SPSS Statistics® 25 (IBM, Armonk,
New York, NY, USA). Categorial data were described using descriptive analysis.
Data regarding overall and progression-free survival data and follow-up recalls were
collected from the electronic patient document and transferred in SPSS. Survival was
assessed using the Kaplan–Meier method as the time between initial therapy and the date
of death or last follow-up (censored) for overall survival, and between initial therapy and
the date of local, regional or distant disease progression or last follow-up (censored) for
progression-free survival and local control rate, accordingly. Data cutoff refers to 31st
December 2020.
5. Conclusions
Surgical tumor therapy with curative intent is based on the achievement of tumor-free
margins wherever possible. If clear margins seem achievable preoperatively, the surgical
procedures including reconstructive strategies should integrate oncological and functional
considerations to obtain an optimal outcome in terms of survival and postoperative quality
of life. Extensive tumor resections in the head and neck area including full-thickness
resections are feasible, and free flap reconstruction offers a versatile tool to restore function
and aesthetics while providing good local disease control rates.
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